Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

PHASE4UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 28, 2018

Study Completion Date

August 31, 2018

Conditions
Benign Prostate Hyperplasia
Interventions
DEVICE

Prolieve

Prolieve® is a transurethral microwave therapy device equipped with automated controls designed to deliver microwave energy to the prostate and balloon-administered compression for the treatment of symptomatic BPH. This device utilizes a transurethral catheter with microwave antenna to heat the prostate, with simultaneous 46 Fr. prostatic urethral catheter balloon-administered compression.

Trial Locations (8)

Unknown

RECRUITING

Winter Park Urology, Orlando

RECRUITING

Winter Park Urology, Orlando

RECRUITING

North Fulton Urology, Roswell

RECRUITING

Regional Urology, Shreveport

RECRUITING

Merrimack Urology Associates PC, Chelmsford

RECRUITING

Albany Medical College Division of Urology, Alabany

RECRUITING

Midtown Urologic Trials, PC, New York

RECRUITING

Mobley Research Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medifocus, Inc.

INDUSTRY